The American Journal of Medicine
Volume 28, Issue 5 , Pages 832-846, May 1960

Mucormycosis:

Two cases of disseminated disease with cultural identification of rhizopus; review of literature

  • Raymond A. McBride, M.D.

      Affiliations

    • From the Department of Pathology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts.
  • ,
  • Joseph M. Corson, M.D.

      Affiliations

    • From the Department of Pathology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts.
  • ,
  • Gustave J. Dammin, M.D.

      Affiliations

    • From the Department of Pathology, Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts.

Boston, Massachusetts, USA

Abstract 


1.1. Two cases of mucormycosis, a usually fatal infection reported with increasing frequency, are presented. In one, a young woman with post-abortal necrosis of the spleen, kidneys and adrenals, and severe uremia, mucormycosis was thought to contribute to the fatal outcome. The second case was a young man with hepatic disease, possibly toxic in origin, and ischémic tubular necrosis. In both cases mucormycosis was disseminated, involving the respiratory and gastrointestinal tracts.

2.2. Rhizopus arrhizus was identified in the second case. This is the sixth case of visceral mucormycosis in which the organism has been identified by culture.

3.3. Clinical and pathologic features of fifty-five cases of mucormycosis reported in the English literature are summarized. In twenty-one of these cases diabetes was present and in thirteen, leukemia or lymphoma. The role of these conditions, as well as that of cortisone and antibiotics in the pathogenesis of mucormycosis, is discussed.

4.4. The most frequently involved sites have been the brain and meninges, usually in diabetic patients. Pulmonary and disseminated forms have predominated in non-diabetic subjects.

5.5. The diagnosis of mucormycosis should be suspected in the diabetic patient who presents a triad of orbital cellulitis, ophthalmoplegia and meningoencephalitis. Some of these patients may have ulceration of the nasal mucosa and here the diagnosis may be established by histologic examination and culture of biopsy material or scrapings. The diagnosis in the pulmonary and gastrointestinal forms of infection remains difficult.

6.6. The experimental data are summarized. Alterations resulting from acute alloxan diabetes, acid osis in the form of ketosis, leukopenia, hyperglycemia and cortisone administration have been found to decrease host resistance to mucormycosis.

7.7. Recovery has been reported in three patients with cerebral mucormycosis. The treatment recommended includes control of the underlying disease, use of vaccines, amphotericin B and iodides.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported in part by a Pathology Research Training Grant (HTS 5274) from the National Heart Institute.

PII: 0002-9343(60)90138-8

The American Journal of Medicine
Volume 28, Issue 5 , Pages 832-846, May 1960